Antimuscarinic agents: Implications and concerns in themanagement of overactive bladder in the elderly

When considering use of an antimus-carinicagent for the treatment of OAB in elderly patients, prescribers should routinely consider the agent's receptor selectivity and ability to cross the BBB. The medical history should include all current medications that may contribute to the anticholinergic burden and cognitive impairment. Patients and caregivers should be educated to recognize anticholinergic adverse effects.